top of page
ENDOMETRIOSIS / UTERINE FIBROID CLINICAL RESEARCH TRIAL
ENDO_UTERINE_CONTENT.jpg

Overview of Clinical Research Trial

This study is being conducted to evaluate the bone mineral density with long-term use of an investigational drug called Relugolix,  a combination tablet, in premenopausal women with heavy menstrual bleeding associated with Uterine Fibroids OR moderate to severe pain associated with Endometriosis.

You may be eligible to take part in the study if you:

  • Are at least 18 to 50 years old at the time of consent and screening

  • A diagnosis of endometriosis that is associated with moderate to severe pain

  • A diagnosis of uterine fibroids confirmed by imaging or review of medical records and reports heavy menstrual bleeding 

You may be compensated for time and travel, up to $ for completed study visit.

Signup online completing contact form below, or email our Patient Recruitment Specialist Autumn Wofford at awofford@invocrc.com.

You can also call us toll free at 803.764.2406.

bottom of page